Article

January 4, 2012

Dr. Jove Graham Discusses How Telemonitoring Improved Patient-Case Manager Contact

Dr. Jove Graham, Research Investigator I, Geisinger Center for Health Research, Danville, PA, discusses the Post-Discharge Monitoring and Readmissions study. In this clip, Dr. Graham provides background and how this study differs from others Geisinger has conducted.

The program attempted to prevent patients from being re-admitted or going to the ER within 30 days of discharge using the telemonitoring program.

Related Videos

Shawn Griffin, MD, sitting for a video interview

Christine Funke, MD

John Michael O'Brien, PharmD, MPH

Kathi Henson, MBA, sitting for a video interview

Mike Fazio, Navista, Cardinal Health

Dr Mingyang Song

Fran Gregory, PharmD, MBA, sitting for a video interview

Casey Koch, PharmD, sitting for a video interview

Dr K. Vish Viswanath

Related Content

Pharmacy Panel at Asembia ASX25 | Image credit: Pearl Steinzor

April 29th 2025

Pharmacy Leaders Discuss Innovation and Patient-Centered Care at Asembia’s AXS25 Summit

At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and navigate a shifting health care environment.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

AJMC

April 22nd 2025

Impact of Telemedicine Use on Outpatient-Related CO2 Emissions: Estimate From a National Cohort

Benjo Delarmente, MD, PhD, MPP Artem Romanov, BA Manying Cui, MS Chi-Hong Tseng, PhD Melody Craff, PhD, MB, BChir Dale Skinner, MSc Michael Hadfield, BS Catherine A. Sarkisian, MD, MSPH Cheryl L. Damberg, PhD A. Mark Fendrick, MD John N. Mafi, MD, MPH

Telemedicine was associated with a monthly avoidance of greenhouse gas emissions equivalent to the emissions of 61,255 to 130,076 passenger vehicles.

Patient navigation | Image credit: AON

April 22nd 2025

With Thyme Care Partnership, AON Achieves $6M in Savings in EOM’s First Performance Period

Related Content

Pharmacy Panel at Asembia ASX25 | Image credit: Pearl Steinzor

April 29th 2025

Pharmacy Leaders Discuss Innovation and Patient-Centered Care at Asembia’s AXS25 Summit

At Asembia’s AXS25 Summit, industry experts explored how pharmacy is evolving to meet rising patient expectations and navigate a shifting health care environment.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

AJMC

April 22nd 2025

Impact of Telemedicine Use on Outpatient-Related CO2 Emissions: Estimate From a National Cohort

Benjo Delarmente, MD, PhD, MPP Artem Romanov, BA Manying Cui, MS Chi-Hong Tseng, PhD Melody Craff, PhD, MB, BChir Dale Skinner, MSc Michael Hadfield, BS Catherine A. Sarkisian, MD, MSPH Cheryl L. Damberg, PhD A. Mark Fendrick, MD John N. Mafi, MD, MPH

Telemedicine was associated with a monthly avoidance of greenhouse gas emissions equivalent to the emissions of 61,255 to 130,076 passenger vehicles.

Patient navigation | Image credit: AON

April 22nd 2025

With Thyme Care Partnership, AON Achieves $6M in Savings in EOM’s First Performance Period

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions